Health care startups in Haidian, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| MoleculeMind | Haidian | Series A | $86.0M | 2026-06-17 |
| X-MAGTECH | Haidian | Series B | $14.8M | 2026-06-04 |
| Surgerii Technology | Haidian | Series D | $100.0M | 2025-12-31 |
| StoneWise | Haidian | Series B | $100.0M | 2021-04-12 |
| CSR Biotech | Haidian | Series B | $45.0M | 2026-03-10 |
| Essentia Biosciences | Haidian | Seed | $14.3M | 2026-01-01 |
| Transcend Vivoscope | Haidian | Series B | $14.5M | 2026-02-10 |
| 7Invensun Technology | Haidian | Series D | $15.0M | 2022-11-02 |
8 rows of the CSV in 5 of its 18 columns.
- The 155 health care startups in Haidian, China have raised $1.1B in total.
- 18 of them closed their most recent round in the last 12 months, $520.1M combined.
- The largest of those rounds is Inno Medicine's $119.2M Series D, dated September 2026.
- The most recent is Zijing Zhikang's $15.0M angel round on 4 November 2026.
- Shenzhen Capital Group is an investor in 2 of them, more than any other fund.
- Biotech is the most common other sector, with 40 companies (26%).
- 18% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (53% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
7 of 155| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| MoleculeMind | MoleculeMind combines artificial intelligence with biotechnology to develop new drugs and biological solutions. | Artificial intelligence | Series A | $86.0M | 2026-06-17 | $114.6M | Shenzhen Capital Group, Lenovo Capital and Incubator Group (LCIG), Sense Capital | 51 to 100 | 2022 |
| X-MAGTECH | X-MAGTECH provides a technology platform for measuring extremely weak magnetic fields. | Health care | Series B | $14.8M | 2026-06-04 | $43.5M | IDG Capital, CAS Star, Everest Venture Capital +1 | 101 to 250 | 2018 |
| CSR Biotech | CSR Biotech provides cell imaging and data processing services for biological research. | Biotech | Series B | $45.0M | 2026-03-10 | $45.0M | Qiming Venture Partners | 51 to 100 | 2019 |
| Transcend Vivoscope | Transcend Vivoscope is a biotechnology company that offers advanced microscopy imaging products and solutions. | Biotech | Series B | $14.5M | 2026-02-10 | $14.5M | China Capital Management, Zefu Innovation, Guangzhou Tongxin Science and Technology Innovation Fund | 11 to 50 | 2016 |
| Essentia Biosciences | Essentia Biosciences develops cell therapies, gene technology drugs, and medical devices. | Biotech | Seed | $14.3M | 2026-01-01 | $14.3M | BioVenture, Haitang Fund, Beijing Molecular Technology | 1 to 10 | 2021 |
| Surgerii Technology | Surgerii Technology develops minimally invasive surgical robots. | Hardware | Series D | $100.0M | 2025-12-31 | $100.0M | Shunwei Capital, SDIC Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund +1 | 11 to 50 | 2014 |
| StoneWise | StoneWise builds an intelligent drug discovery platform for pharmaceutical research. | Artificial intelligence | Series B | $100.0M | 2021-04-12 | Legend Capital, Luminous Ventures (former Lightspeed China Partners), Hillhouse Ventures +1 | 51 to 100 | 2018 |
Table 1. Health care startups in Haidian, China: the 7 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 155.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Surgerii Technology | Surgerii Technology develops minimally invasive surgical robots. | Hardware | Series D | $100.0M | 2025-12-31 | $100.0M | Shunwei Capital, SDIC Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund +1 | 11 to 50 | 2014 |
| 2 | MoleculeMind | MoleculeMind combines artificial intelligence with biotechnology to develop new drugs and biological solutions. | Artificial intelligence | Series A | $86.0M | 2026-06-17 | $114.6M | Shenzhen Capital Group, Lenovo Capital and Incubator Group (LCIG), Sense Capital | 51 to 100 | 2022 |
| 3 | CSR Biotech | CSR Biotech provides cell imaging and data processing services for biological research. | Biotech | Series B | $45.0M | 2026-03-10 | $45.0M | Qiming Venture Partners | 51 to 100 | 2019 |
| 4 | X-MAGTECH | X-MAGTECH provides a technology platform for measuring extremely weak magnetic fields. | Health care | Series B | $14.8M | 2026-06-04 | $43.5M | IDG Capital, CAS Star, Everest Venture Capital +1 | 101 to 250 | 2018 |
| 5 | Transcend Vivoscope | Transcend Vivoscope is a biotechnology company that offers advanced microscopy imaging products and solutions. | Biotech | Series B | $14.5M | 2026-02-10 | $14.5M | China Capital Management, Zefu Innovation, Guangzhou Tongxin Science and Technology Innovation Fund | 11 to 50 | 2016 |
| 6 | Essentia Biosciences | Essentia Biosciences develops cell therapies, gene technology drugs, and medical devices. | Biotech | Seed | $14.3M | 2026-01-01 | $14.3M | BioVenture, Haitang Fund, Beijing Molecular Technology | 1 to 10 | 2021 |
Table 2. Health care startups in Haidian, China: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 2 | 1% | 1 | MoleculeMind |
| 2 | CAS Star | Startup incubator | Xian, China | 2 | 1% | 2 | KansenBio, X-MAGTECH |
| 3 | Zhongguancun Science City Science | Venture capital firm | Haidian, China | 2 | 1% | 1 | X-MAGTECH |
| 4 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 2 | 1% | 1 | CSR Biotech |
| 5 | Tsinghua Innovation Ventures | Venture capital firm | Beijing, China | 2 | 1% | ||
| 6 | Frees Fund | Venture capital firm | Beijing, China | 2 | 1% | ||
| 7 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 1 | 1% | 1 | MoleculeMind |
| 8 | Sense Capital | Private equity firm | Beijing, China | 1 | 1% | 1 | MoleculeMind |
| 9 | Everest Venture Capital | Venture capital firm | Beijing, China | 1 | 1% | 1 | X-MAGTECH |
| 10 | IDG Capital | Private equity firm | Beijing, China | 1 | 1% | 1 | X-MAGTECH |
| 11 | SDIC Venture Capital | Venture capital firm | Xicheng, China | 1 | 1% | 1 | Surgerii Technology |
| 12 | Loyal Valley Capital | Private equity firm | Shanghai, China | 1 | 1% | 1 | Surgerii Technology |
| 13 | Shanghai Biomedical Industrial Equity Investment Fund | Venture capital firm | Huangpu, China | 1 | 1% | 1 | Surgerii Technology |
| 14 | Shunwei Capital | Venture capital firm | Beijing, China | 1 | 1% | 1 | Surgerii Technology |
| 15 | Legend Capital | Venture capital firm | Beijing, China | 1 | 1% |
Table 3. Health care startups in Haidian, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups in Haidian, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Haidian, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 6% | $15.0M |
| October 2026 | 1 | 6% | $14.9M |
| September 2026 | 1 | 6% | $119.2M |
| August 2026 | 1 | 6% | $52.1M |
| June 2026 | 5 | 28% | $115.5M |
| April 2026 | 2 | 11% | $733K |
| March 2026 | 2 | 11% | $59.5M |
| February 2026 | 2 | 11% | $28.9M |
| January 2026 | 2 | 11% | $14.3M |
| December 2025 | 1 | 6% | $100.0M |
Table 6. Health care startups in Haidian, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 17 | 11% | $420.1M |
| 2025 | 12 | 8% | $120.8M |
| 2024 | 10 | 6% | $15.5M |
| 2023 | 9 | 6% | $5.4M |
| 2022 | 10 | 6% | $111.5M |
| 2021 | 3 | 2% | $100.0M |
Table 7. Health care startups in Haidian, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 9 | 6% |
| 2020 to 2022 | 18 | 12% |
| 2015 to 2019 | 54 | 35% |
| 2010 to 2014 | 50 | 32% |
| Before 2010 | 23 | 15% |
Table 8. Health care startups in Haidian, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 11 | 8% |
| 11 to 50 | 70 | 53% |
| 51 to 100 | 19 | 15% |
| 101 to 250 | 19 | 15% |
| 251 to 500 | 9 | 7% |
| 1,001 to 5,000 | 3 | 2% |
Table 9. Health care startups in Haidian, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Haidian, China. On 16 November 2026 that is 155 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 7 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 155 rows: 38 have no round amount, 0 no city and 51 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Haidian, China are on the list?
- 155, in the file dated 16 November 2026. 18 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 155 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.